COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 181 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,002 | +4.0% | 2,103 | 0.0% | 0.00% | – |
Q2 2023 | $45,193 | +90286.0% | 2,103 | 0.0% | 0.00% | – |
Q1 2023 | $50 | -10.7% | 2,103 | -13.2% | 0.00% | – |
Q4 2022 | $56 | -99.9% | 2,423 | 0.0% | 0.00% | – |
Q3 2022 | $43,000 | +2.4% | 2,423 | +1.4% | 0.00% | – |
Q2 2022 | $42,000 | +366.7% | 2,390 | +443.2% | 0.00% | – |
Q1 2022 | $9,000 | -89.5% | 440 | -90.8% | 0.00% | -100.0% |
Q4 2021 | $86,000 | -45.2% | 4,799 | -39.7% | 0.00% | 0.0% |
Q3 2021 | $157,000 | +946.7% | 7,955 | +1183.1% | 0.00% | – |
Q2 2021 | $15,000 | 0.0% | 620 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | +25.0% | 620 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | -81.5% | 620 | -80.1% | 0.00% | -100.0% |
Q3 2020 | $65,000 | +400.0% | 3,112 | +332.2% | 0.00% | – |
Q2 2020 | $13,000 | -7.1% | 720 | -16.8% | 0.00% | – |
Q1 2020 | $14,000 | -22.2% | 865 | 0.0% | 0.00% | – |
Q4 2019 | $18,000 | -81.6% | 865 | -89.8% | 0.00% | -100.0% |
Q3 2019 | $98,000 | – | 8,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |